Hackman Jeffrey S.insider trades

In SEC Form 4 filings, Hackman Jeffrey S. is listed as Chief Executive Officer of Fennec Pharmaceuticals Inc. (FENC). Hackman Jeffrey S. reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 13.

Companies and roles

Company	Role	Transactions	Last filed
FENCFennec Pharmaceuticals Inc.	Chief Executive Officer	3	Oct 13

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-08-31

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
FENCFennec Pharmaceuticals Inc.	Oct 12	Oct 13	A	2,224	$5.53	$12,299	69,685	No	Form 4
FENCFennec Pharmaceuticals Inc.	Sep 30	Oct 1	A	1,159	$0.00	$0	67,461	No	Form 4
FENCFennec Pharmaceuticals Inc.	Aug 31	Aug 31	A	1,159	$0.00	$0	66,302	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.